These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28741720)

  • 1. Alteplase for Acute Ischemic Stroke after Heparin Reversal with Protamine: A Case Report and Review.
    Fontaine GV; Smith SM
    Pharmacotherapy; 2017 Oct; 37(10):e103-e106. PubMed ID: 28741720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis After Protamine Reversal of Heparin for Acute Ischemic Stroke After Cardiac Catheterization: Case Report and Literature Review.
    Warner DS; Schwartz BG; Babygirija R; Rovin RA; Kassam AB; Biddick L; Sajjad R; Chohan A; Panichpisal K
    Neurologist; 2018 Nov; 23(6):194-196. PubMed ID: 30379743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombolysis Following Heparin Reversal With Protamine Sulfate in Acute Ischemic Stroke: Case Series and Literature Review.
    Ranasinghe T; Mays T; Quedado J; Adcock A
    J Stroke Cerebrovasc Dis; 2019 Oct; 28(10):104283. PubMed ID: 31324409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Use of Antiplatelet Agents and Heparin in the 24-Hour Postintravenous Alteplase Window for Neurointervention.
    Binning MJ; Maxwell CR; McAree M; Veznedaroglu E; Felbaum DR; Arthur A; Goyal N; Wolfe SQ; Tschoe C; Crowley RW; Levy E; Vakharia K; Rai HH; Pandey AS; Daou BJ; Tawk RG; Ringer AJ; Liebman KM
    Neurosurgery; 2021 Mar; 88(4):746-750. PubMed ID: 33442725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Andexanet Alfa, the Possible Alternative to Protamine for Reversal of Unfractionated Heparin.
    Maneno JN; Ness GL
    Ann Pharmacother; 2021 Feb; 55(2):261-264. PubMed ID: 32667214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute ischemic stroke after cardiac catheterization: the protamine low-dose recombinant tissue plasminogen activator pathway.
    Guevara C; Quijada A; Rosas C; Bulatova K; Lara H; Nieto E; Morales M
    Blood Coagul Fibrinolysis; 2017 Apr; 28(3):261-263. PubMed ID: 27214037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individualized heparin and protamine management improves rotational thromboelastometric parameters and postoperative hemostasis in valve surgery.
    Vonk AB; Veerhoek D; van den Brom CE; van Barneveld LJ; Boer C
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):235-41. PubMed ID: 24342152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombolysis for Acute Ischemic Stroke After Protamine Reversal of Heparin.
    Danoun O; Sachar P; Rajamani K
    Am J Ther; 2018; 25(5):e552-e554. PubMed ID: 29199997
    [No Abstract]   [Full Text] [Related]  

  • 9. Heparin reversal in off-pump coronary artery bypass surgery: complete, partial, or no reversal?
    Gatti G; Pugliese P
    Cardiovasc Surg; 2002 Jun; 10(3):245-50. PubMed ID: 12044433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of differing rates of protamine reversal of heparin anticoagulation.
    Wakefield TW; Hantler CB; Wrobleski SK; Crider BA; Stanley JC
    Surgery; 1996 Feb; 119(2):123-8. PubMed ID: 8571194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of i.v. alteplase therapy up to 4.5 hours after acute ischemic stroke onset.
    Otwell JL; Phillippe HM; Dixon KS
    Am J Health Syst Pharm; 2010 Jul; 67(13):1070-4. PubMed ID: 20554592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Readministration of intravenous alteplase in acute ischemic stroke patients: case series and systematic review.
    Qureshi AI; Malik AA; Freese M; Thompson MJ; Khan AA; Suri MF
    Am J Emerg Med; 2015 Feb; 33(2):307.e1-4. PubMed ID: 25190550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute ischemic stroke: imaging-guided tenecteplase treatment in an extended time window.
    Parsons MW; Miteff F; Bateman GA; Spratt N; Loiselle A; Attia J; Levi CR
    Neurology; 2009 Mar; 72(10):915-21. PubMed ID: 19273826
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safe use of alteplase in a 10 months old infant with cardio-embolic stroke.
    Rener-Primec Z; Švigelj V; Vesel S; Lovrič D; Škofljanec A
    Eur J Paediatr Neurol; 2013 Sep; 17(5):522-5. PubMed ID: 23603009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of bivalirudin to heparin with protamine reversal in patients undergoing cardiac surgery with cardiopulmonary bypass: the EVOLUTION-ON study.
    Dyke CM; Smedira NG; Koster A; Aronson S; McCarthy HL; Kirshner R; Lincoff AM; Spiess BD
    J Thorac Cardiovasc Surg; 2006 Mar; 131(3):533-9. PubMed ID: 16515902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of protamine dosing variation on bleeding and transfusion after heparinisation for cardiopulmonary bypass.
    Kunz SA; Miles LF; Ianno DJ; Mirowska-Allen KL; Matalanis G; Bellomo R; Seevanayagam S
    Perfusion; 2018 Sep; 33(6):445-452. PubMed ID: 29544405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is heparin reversal required for the safe performance of percutaneous endovascular aortic aneurysm repair?
    Jabori S; Jimenez JC; Gabriel V; Quinones-Baldrich WJ; Derubertis BG; Farley S; Gelabert HA; Rigberg DA
    Ann Vasc Surg; 2013 Nov; 27(8):1049-53. PubMed ID: 24011808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of protamine to rapidly reverse anticoagulant effect of unfractionated heparin in patients undergoing percutaneous coronary intervention.
    Patel AA; White CM; Coleman CI
    Conn Med; 2007 Feb; 71(2):93-5. PubMed ID: 17393902
    [No Abstract]   [Full Text] [Related]  

  • 20. Arterial occlusion sites on magnetic resonance angiography influence the efficacy of intravenous low-dose (0.6 mg/kg) alteplase therapy for ischaemic stroke.
    Nakashima T; Toyoda K; Koga M; Matsuoka H; Nagatsuka K; Takada T; Naritomi H; Minematsu K
    Int J Stroke; 2009 Dec; 4(6):425-31. PubMed ID: 19930051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.